Table 2. The normalized number of cells at different cell death phases (CDP) according to treatment condition.
Normalized number of cells (%) | ||||
Treatment condition | CDP0 | CDP1 | CDP2 | CDP3 |
Control | 93.61±4.47 | 1.68±2.38 | 2.84±1.54 | 1.85±0.55 |
Amphotericin B | 70.49±5.86 | 5.47±0.97 | 13.57±0.24 | 10.46±4.64 |
Flucytosine | 71.16±4.69 | 7.44±2.94 | 1.90±0.07 | 3.88±1.66 |
Allicin | 79.45±3.92 | 5.83±3.22 | 8.38±3.23 | 6.32±3.91 |
Amphotericin B + Allicin | 49.97±12.23 | 13.43±4.37 | 18.53±1.83 | 18.05±6.02 |
Flucytosine + Allicin | 72.49±12.70 | 10.22±2.99 | 7.93±5.98 | 9.34±9.72 |
Amphotericin B + Flucytosine +Allicin | 52.51±2.60 | 9.86±6.78 | 24.07±3.87 | 13.55±0.31 |
The CDP was assessed by analyzing SEM and AFM images of cells treated for 24 hours.